Another subcutaneous injectable version (WEGOVY) is approved for the same indication of obesity or overweight with at least one weight-related comorbidity, in combination with diet and exercise [31,32,33]
Novo Nordisk reined in its growth forecasts for the year in its second-quarter financial results update, blaming "persistent use of compounded GLP-1s, slower-than-expected market expansion, and competition." Compounding of semaglutide should have come to a halt in the US since the drug was removed from the FDA list of medicines in short supply, but various companies continue to provide compounded GLP-1s under a loophole that allows the sale of 'personalised' formulations
For these two independent reasons, the best avenue for obtaining the benefits of Glutathione directly through consumption is through whole foods
Cardiovascular mortality Compared with placebo, tirzepatide and the GLP-1RA class significantly reduced the risk of CV mortality (HR 0.77, 95% CI 0.660.90 and HR 0.87, 95% CI 0.810.92, respectively).- Heterogeneity across studies was low (Q = 11.76, p = 0.227
)
